Next week, it is time for the annual event Nordic Life Science Days, this year held in Medicon Valley, and on the agenda are diabetes, funding and de novo research.
The event will take place at Malmö Convention Center on September 12-15 and the organizers promise attendees more opportunities for networking, brainstorming and partnering.
“Everything is set up to facilitate networking. We are making it easy for people to meet face-to-face in a secure environment. There is an online platform, EBD Group partnering system PartneringONE, to help people set up meetings. The purpose is to create or follow-up on relationships. You can meet with investors, public agencies, or a big pharmaceutical company looking for new drugs Last year, there were 2 200 face-to-face meetings. There also will be informal networking receptions on- and off-site,” says NLSDays Managing Director Olivier Duchamp.
New for this year is also that the event will start half-a-day earlier and run two new sessions right before and during the welcome reception. “One is the Startup Challenge @ NLSDays, in partnership with J&J Innovation, the second one will be the Academics Catwalk, allowing life science innovators to present during three-minute elevator pitches,” continues Duchamp.
This also will be the fifth year the Nordic Star Awards will be presented at the end of the conference, honoring three innovative life science companies in the Nordic region. NLSDays Managing Director Olivier Duchamp discussed the vision and goals for the conference, the agenda and enhanced networking activities.
The event will of course also tackle the issues facing the sector and the Super Sessions in particular spark lively debate.
“We’ve canvassed our members and networks extensively and this year I believe come up with an unmissable programme. In particular, I would recommend three of the Super Sessions – Diabetes Game Changers, Funding Excess Trials and Tapping the Potential of De Novo Service Provider Research,” says Jonas Ekstrand, Director General of SwedenBIO, the Swedish life science industry organization which founded the event five years ago with Bionordic.
Diabetes is Super Session I and deals with game changers in diabetes treatment. Diabetes research has long been a strength in the Nordic region, where especially Denmark has played a leading role. The belief is now we are entering an era of potentially disruptive solutions and so the session will focus on new developments such as closed loop systems and ultrafast acting insulins and their impact on patients with unstable blood glucose.
Super Session 4 seeks to open the way to new methods of funding excess clinical stage projects. Increasingly biopharma companies find they have built pipelines that offer more development opportunities than their resources allow them to pursue. This can result in promising clinical trials being moved down the priority list and their execution delayed – leading to a decline in asset value against a fixed patent expiration date. One potential solution is to package complementary trials and bring them into collaborations with investors, CROs or other organizations and fund the execution of these trials outside the biopharma company. While there are several potential advantages of this approach, the session will also address more difficult questions such as: What would be the primary driving forces for different parties to engage in this type of collaboration? Are there also complications with the phenomenon? How does an excess of promising assets within large biopharma companies affect other parts of the life science ecosystem?
Finally, Super Session 5 will seek to raise awareness of the large amount of de novo research carried out by service providers and its added value to client companies. They provide much more than just an extra pair of hands, often spending large amounts on in house development of their services. This in turn enables smaller biopharmas to concentrate on core competencies.
There will also be a pre-conference fringe on September 12th with two main events. First a coach tour to Lund, only 20 km outside Malmö to visit the recently inaugurated MAX IV facility and the under construction ESS. And then, don’t miss the Academic’s Catwalk and the Startups’ Challenge just before the Welcome Get Together.